179 related articles for article (PubMed ID: 25546932)
1. [Therapeutic value of lymphadenectomy in ovarian cancer patients].
Gmyrek L; Jońska-Gmyrek J; Żółciak-Siwińska A
Ginekol Pol; 2014 Oct; 85(10):788-91. PubMed ID: 25546932
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
[TBL] [Abstract][Full Text] [Related]
4. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
[TBL] [Abstract][Full Text] [Related]
6. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
LaFargue CJ; Bristow RE
Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
[No Abstract] [Full Text] [Related]
7. [Therapeutic and prognostic value of lymphadenectomy in gynecological oncology].
Perzyło K; Miotła P; Lis E; Rechberger T
Ginekol Pol; 2013 Jul; 84(7):630-6. PubMed ID: 24032276
[TBL] [Abstract][Full Text] [Related]
8. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
[TBL] [Abstract][Full Text] [Related]
9. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
[TBL] [Abstract][Full Text] [Related]
10. The effect of lymphadenectomy in advanced ovarian cancer according to residual tumor status: A population-based study.
Zhou J; Zhang WW; Zhang QH; He ZY; Sun JY; Chen QH; Wu SG
Int J Surg; 2018 Apr; 52():11-15. PubMed ID: 29432972
[TBL] [Abstract][Full Text] [Related]
11. Does debulking of enlarged positive lymph nodes improve survival in different gynaecological cancers?
Somashekhar SP
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):870-83. PubMed ID: 26043964
[TBL] [Abstract][Full Text] [Related]
12. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.
Desteli GA; Gultekin M; Usubutun A; Yuce K; Ayhan A
World J Surg Oncol; 2010 Nov; 8():106. PubMed ID: 21114870
[TBL] [Abstract][Full Text] [Related]
14. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
[TBL] [Abstract][Full Text] [Related]
15. Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
Signorelli M; Guerra L; Pirovano C; Crivellaro C; Fruscio R; Buda A; Cuzzucrea M; Elisei F; Ceppi L; Messa C
Gynecol Oncol; 2013 Nov; 131(2):395-9. PubMed ID: 23988414
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
[TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]